Stifel Financial
PPH icon

Stifel Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

Stifel Financial’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Sell
14,207
-36,883
-72% -$3.82M ﹤0.01% 2266
2026
Q1 		$5.31M Sell
51,090
-5,602
-10% -$597K ﹤0.01% 1313
2025
Q4 		$5.85M Buy
56,692
+44,713
+373% +$4.35M 0.01% 1245
2025
Q3 		$1.08M Buy
11,979
+523
+5% +$45.8K ﹤0.01% 2349
2025
Q2 		$1.01M Sell
11,456
-6
-0.1% -$520 ﹤0.01% 2324
2025
Q1 		$1.04M Buy
11,462
+61
+0.5% +$5.49K ﹤0.01% 2196
2024
Q4 		$984K Buy
11,401
+3,591
+46% +$325K ﹤0.01% 2253
2024
Q3 		$742K Buy
7,810
+924
+13% +$87.8K ﹤0.01% 2420
2024
Q2 		$630K Buy
6,886
+36
+0.5% +$3.21K ﹤0.01% 2468
2024
Q1 		$621K Sell
6,850
-6,635
-49% -$581K ﹤0.01% 2480
2023
Q4 		$1.1M Buy
13,485
+2,735
+25% +$214K ﹤0.01% 2085
2023
Q3 		$859K Sell
10,750
-669
-6% -$53.9K ﹤0.01% 2145
2023
Q2 		$899K Sell
11,419
-287
-2% -$22.5K ﹤0.01% 2150
2023
Q1 		$909K Sell
11,706
-4,160
-26% -$321K ﹤0.01% 2123
2022
Q4 		$1.23M Sell
15,866
-15,488
-49% -$1.14M ﹤0.01% 1845
2022
Q3 		$2.11M Buy
31,354
+36
+0.1% +$2.65K ﹤0.01% 1429
2022
Q2 		$2.41M Buy
31,318
+23,695
+311% +$1.85M ﹤0.01% 1382
2022
Q1 		$608K Hold
7,623
– – ﹤0.01% 2465
2021
Q4 		$587K Hold
7,623
– – ﹤0.01% 2507
2021
Q3 		$555K Hold
7,623
– – ﹤0.01% 2521
2021
Q2 		$557K Sell
7,623
-573
-7% -$40.9K ﹤0.01% 2522
2021
Q1 		$566K Sell
8,196
-3,729
-31% -$257K ﹤0.01% 2401
2020
Q4 		$793K Buy
+11,925
New +$764K ﹤0.01% 2021

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Stifel Financial's PPH Position: Q2 2026 in Review

Stifel Financial reduced its VanEck Pharmaceutical ETF (PPH) stake by 72% in Q2 2026, selling an estimated $3.82M and leaving 14,207 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2266.

Stifel Financial first reported a position in PPH in Q4 2020 and has held it in 23 quarters since. The position peaked at $5.85M in Q4 2025. 147 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Stifel Financial held 14,207 shares of VanEck Pharmaceutical ETF worth $1.55M as of Q2 2026.
  • Stifel Financial sold 36,883 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $3.82M.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2266 holding.
  • Stifel Financial first reported a position in VanEck Pharmaceutical ETF in Q4 2020 and has held it in 23 quarters since.
  • Stifel Financial's VanEck Pharmaceutical ETF position peaked at $5.85M in Q4 2025.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.